share_log

誉衡药业(002437.SZ):目前推广的第一三共产品均为心脑血管领域药物

Harbin Gloria Pharmaceuticals (002437.SZ): Currently promoting first and third joint products are cardiovascular and cerebrovascular drugs.

Gelonghui Finance ·  Jul 8 19:28

Harbin Gloria Pharmaceuticals (002437.SZ) recently stated during a reception for institutional investors that the company has been cooperating with Daiichi Sankyo since 2015. The two parties have had a good cooperative relationship for nearly 10 years, and the cooperation is stable. Currently, the Daiichi Sankyo products promoted by the company are all cardiovascular and cerebrovascular drugs.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment